Aflac Incorporated (NYSE:AFL) Shares Acquired by Capital Investment Advisors LLC

Capital Investment Advisors LLC increased its position in shares of Aflac Incorporated (NYSE:AFL) by 1.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 22,111 shares of the financial services provider’s stock after acquiring an additional 311 shares during the period. Capital Investment Advisors LLC’s holdings in Aflac were worth $2,472,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the business. Y.D. More Investments Ltd bought a new position in shares of Aflac during the 2nd quarter valued at about $25,000. OFI Invest Asset Management bought a new stake in shares of Aflac in the 1st quarter worth approximately $29,000. Dixon Mitchell Investment Counsel Inc. acquired a new stake in Aflac during the first quarter valued at approximately $34,000. Cedar Wealth Management LLC bought a new stake in Aflac during the first quarter worth approximately $50,000. Finally, Fairscale Capital LLC acquired a new position in Aflac in the second quarter worth approximately $54,000. 67.44% of the stock is currently owned by institutional investors.

Aflac Stock Down 0.4 %

Aflac stock opened at $114.50 on Friday. Aflac Incorporated has a twelve month low of $75.07 and a twelve month high of $115.50. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.10 and a current ratio of 0.10. The firm has a market cap of $65.06 billion, a PE ratio of 12.64, a P/E/G ratio of 2.62 and a beta of 0.95. The firm’s 50 day moving average price is $109.40 and its two-hundred day moving average price is $95.91.

Aflac (NYSE:AFL) last posted its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.83 earnings per share for the quarter, topping analysts’ consensus estimates of $1.60 by $0.23. Aflac had a net margin of 28.35% and a return on equity of 16.22%. The business had revenue of $5.14 billion for the quarter, compared to the consensus estimate of $4.10 billion. During the same period in the prior year, the business posted $1.58 earnings per share. Aflac’s revenue for the quarter was down .7% compared to the same quarter last year. On average, research analysts predict that Aflac Incorporated will post 6.76 EPS for the current fiscal year.

Aflac Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, September 2nd. Stockholders of record on Wednesday, August 21st were paid a dividend of $0.50 per share. The ex-dividend date was Wednesday, August 21st. This represents a $2.00 annualized dividend and a dividend yield of 1.75%. Aflac’s dividend payout ratio (DPR) is 22.08%.

Insider Activity

In other Aflac news, Director Thomas J. Kenny sold 2,000 shares of the firm’s stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $98.94, for a total transaction of $197,880.00. Following the transaction, the director now directly owns 18,158 shares in the company, valued at $1,796,552.52. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.90% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on the company. UBS Group increased their price objective on Aflac from $84.00 to $109.00 and gave the company a “neutral” rating in a research report on Wednesday, August 14th. Truist Financial upped their target price on Aflac from $82.00 to $100.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Wells Fargo & Company increased their price target on Aflac from $90.00 to $106.00 and gave the company an “equal weight” rating in a research report on Thursday, October 10th. Barclays started coverage on Aflac in a report on Wednesday, September 4th. They set an “underweight” rating and a $96.00 price objective on the stock. Finally, TD Cowen started coverage on shares of Aflac in a report on Wednesday, October 9th. They issued a “hold” rating and a $102.00 target price for the company. Three investment analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $97.53.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.